Should You Mimic Kamunting Street Capital’s Bets On Alphabet, Inc (GOOG), American Airlines Group Inc (AAL), and Others?

Kamunting Street sold 25% of its stake in Goldman Sachs Group, Inc. (NYSE:GS) in the second quarter. The fund started the third quarter with a total of 30,000 shares of the company, which had a total value of $4.46 million. The stock returned 9% during the third quarter and has pushed even higher in the fourth quarter on positive sentiment for banks following Donald Trump’s upset win in the Presidential elections.

At the end of the second quarter, a total of 68 of the hedge funds tracked by Insider Monkey were long Goldman Sachs, down by 1% quarter-over-quarter. More specifically, Berkshire Hathaway was the largest shareholder of Goldman Sachs Group, Inc. (NYSE:GS), with a stake worth $1.63 billion as of the end of June. Trailing Berkshire Hathaway was Greenhaven Associates, which amassed a stake valued at $556.8 million. Eagle Capital Management, Pzena Investment Management, and Masters Capital Management also held valuable positions in the company.

Lastly, Kamunting had 164,946 shares of Endo Health Solutions, Inc (NASDAQ:ENDP) in its equity portfolio at the end of the June quarter. The value of the position was over $2.57 million on June 30 and the bet paid off, as the stock returned 29.2% during the third quarter.

At Q2’s end, 36 hedge funds in our database were bullish on Endo, a 27% slide from one quarter earlier. The largest stake in Endo Health Solutions Inc (NASDAQ:ENDP) was held by Paulson & Co, which reported holding $139.6 million worth of stock as of the end of June. It was followed by Camber Capital Management with a $78.7 million position. Other investors bullish on the company included AQR Capital Management, Point State Capital, and Point72 Asset Management.

Disclosure: None